HALIFAX, Nova Scotia, May 12, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its regulatory strategy by receiving the CE mark for ...
The Multiplo® TP/nTP test integrates the detection of both treponemal (TP) and non-treponemal (nTP) antibodies into a single diagnostic tool. By targeting biomarkers associated with both active and ...
HALIFAX, August 13, 2024 (Newswire.com) - Today, MedMira Inc. (MedMira) (TSXV:MIR) announces it will conduct full clinical trials for its unique Multiplo ® Complete Syphilis (TP/nTP) Antibody Test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results